Biotech and Pharmaceuticals
Under threat, Weight Watchers enters obesity drug space. Here’s what it means for the stock
WW International is steering hard in a new direction, hoping to turn the growing interest in obesity medications to its advantage. On paper, the new strategy could be the answer to its problems, but significant execution risks remain. Shares of the Weight Watchers parent are up nearly 50% on Tuesday after the company announced plans […]
Read More
Republican states say the FDA doesn’t have the authority to override state abortion pill bans
Boxes of the medication Mifepristone used to induce a medical abortion are prepared for patients at Planned Parenthood health center in Birmingham, Alabama, March 14, 2022. Evelyn Hockstein | Reuters The Food and Drug Administration’s power to approve drugs does not override state bans on the abortion pill, a coalition of Republican attorneys general told […]
Read More
California governor states state will never do enterprise with Walgreens in excess of placement on abortion capsule
California Gov. Gavin Newsom properly quashed a remember try last calendar year in California. Asked if he is acquiring ready for a presidential run, Newsom insisted that was not the scenario. Justin Sullivan | Getty Images California Gov. Gavin Newsom on Monday stated the state would no more time do small business with Walgreens, soon […]
Read More
FDA will review Eisai’s and Biogen’s Alzheimer’s treatment Leqembi with decision on full approval expected in early July
Andrew Brookes | Image Source | Getty Images The Food and Drug Administration will make a decision on whether to fully approve Eisai‘s and Biogen‘s Alzheimer’s treatment Leqembi by July 6, the companies announced on Monday. Leqembi is an antibody treatment that targets brain plaque associated with the mind-robbing disease. It is administered intravenously twice […]
Read More
A Stanford doctor who studied people who live to 110 on how humanity and AI will master aging
As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now she is at the forefront of biotech efforts to turn longevity science knowledge into medicine. As CEO and co-founder of BioAge, a clinical stage biotech developing […]
Read More
U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks
Tesla Motors CEO Elon Musk unveils a new all-wheel-drive version of the Model S car in Hawthorne, California October 9, 2014. Lucy Nicholson | Reuters On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions […]
Read More
FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks
The Food and Drug Administration’s independent panel of advisors on Wednesday recommended GlaxoSmithKline’s RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over nervous system disorders that may be tied to the shot. Ten of the FDA advisors said the safety data on GSK’s vaccine was adequate, while two said […]
Read More
Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance
An Eli Lilly & Co. logo is seen on a box of insulin medication in this arranged photograph at a pharmacy in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Drugmaker Eli Lilly & Co. on Wednesday said it will cut prices of its most commonly prescribed insulins by 70% and cap monthly out-of-pocket […]
Read More
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration’s independent advisors on Tuesday recommended Pfizer’s RSV vaccine for adults ages 60 and older, despite safety concerns after two people who received the shot developed a rare neurological disorder. Though a majority of the FDA committee […]
Read More
This biotech startup has a possibility to get a piece of the profitable obesity drug market, analysts say
It really is been challenging to pass up the buzz about a new course of weight problems remedies , but 1 massive disadvantage to these therapies is that they involve a weekly injection. Enter biotech startup Composition Therapeutics , which is hoping to change that routine with oral GLP-1 formulations for being overweight and kind […]
Read More